BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 35219245)

  • 21. COVID-19 pneumonia: lessons learned, challenges, and preparing for the future.
    Ufuk F; Savaş R
    Diagn Interv Radiol; 2022 Nov; 28(6):576-585. PubMed ID: 36550758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 and Lung Cancer Survival: An Updated Systematic Review and Meta-Analysis.
    Oldani S; Petrelli F; Dognini G; Borgonovo K; Parati MC; Ghilardi M; Dottorini L; Cabiddu M; Luciani A
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer over a 2-Year Period at a Canadian Academic Center.
    Kasymjanova G; Rizzolo A; Pepe C; Friedmann JE; Small D; Spicer J; Lecavalier-Barsoum M; Sultanem K; Wang H; Spatz A; Cohen V; Agulnik JS
    Curr Oncol; 2022 Nov; 29(11):8677-8685. PubMed ID: 36421337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of ensemble machine learning algorithms on exome datasets for predicting early diagnosis of cancers.
    Pasha Syed AR; Anbalagan R; Setlur AS; Karunakaran C; Shetty J; Kumar J; Niranjan V
    BMC Bioinformatics; 2022 Nov; 23(1):496. PubMed ID: 36401182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the impact of COVID-19 on cancer declarations in Quebec, Canada.
    Ramanakumar AV; Annie B; Frederic L; Christine B; Cathy R; Jean L
    Cancer Med; 2023 Mar; 12(5):6260-6269. PubMed ID: 36385491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network.
    Papanikolaou C; Rapti V; Stellas D; Stefanou DT; Syrigos K; Pavlakis GN; Souliotis VL
    Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of the COVID-19 pandemic on diagnosis and treatment of patients with soft tissue and bone sarcomas or aggressive benign musculoskeletal diseases: A single-center retrospective study (SarCorD study).
    Onesti CE; Vari S; Nardozza F; Maggi G; Minghelli D; Rossi B; Sperati F; Checcucci E; Faltyn W; Cercato MC; Cosimati A; Biagini R; Ciliberto G; Ferraresi V
    Front Oncol; 2022; 12():1000056. PubMed ID: 36249051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 Pandemic: Impact on Cancer Patients.
    Rucinska M; Nawrocki S
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231769
    [No Abstract]   [Full Text] [Related]  

  • 29. Determinants of COVID-19 Outcome as Predictors of Delayed Healthcare Services among Adults ≥50 Years during the Pandemic: 2006-2020 Health and Retirement Study.
    Beydoun HA; Beydoun MA; Alemu BT; Weiss J; Hossain S; Gautam RS; Zonderman AB
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient care.
    Ferrara P; Dallagiacoma G; Alberti F; Gentile L; Bertuccio P; Odone A
    Prev Med; 2022 Nov; 164():107264. PubMed ID: 36150446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical course of COVID-19 infection in a melanoma patient treated with nivolumab and bempegaldesleukin: a case report.
    Anastasopoulou A; Gkoufa A; Diamantopoulos P; Kazanas S; Eliadi I; Samarkos M; Gogas H
    Immunotherapy; 2022 Sep; 14(13):1015-1020. PubMed ID: 35852114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020.
    Trama A; Bernasconi A; Botta L; Di Cosimo S; Miceli R; Claps M; Badenchini F; Lillini R; Rubino M; Lasalvia P
    Int J Cancer; 2022 Nov; 151(9):1502-1511. PubMed ID: 35704342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed visit and treatment of lung cancer during the coronavirus disease 2019 pandemic in Japan: a retrospective study.
    Terashima T; Tsutsumi A; Iwami E; Kuroda A; Nakajima T; Eguchi K
    J Int Med Res; 2022 May; 50(5):3000605221097375. PubMed ID: 35579175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organisation of cancer care in troubling times: A scoping review of expert guidelines and their implementation during the COVID-19 pandemic.
    Bogaert B; Buisson V; Kozlakidis Z; Saintigny P
    Crit Rev Oncol Hematol; 2022 May; 173():103656. PubMed ID: 35337970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario.
    Cantini L; Mentrasti G; Russo GL; Signorelli D; Pasello G; Rijavec E; Russano M; Antonuzzo L; Rocco D; Giusti R; Adamo V; Genova C; Tuzi A; Morabito A; Gori S; Verde N; Chiari R; Cortellini A; Cognigni V; Pecci F; Indini A; De Toma A; Zattarin E; Oresti S; Pizzutilo EG; Frega S; Erbetta E; Galletti A; Citarella F; Fancelli S; Caliman E; Della Gravara L; Malapelle U; Filetti M; Piras M; Toscano G; Zullo L; De Tursi M; Di Marino P; D'Emilio V; Cona MS; Guida A; Caglio A; Salerno F; Spinelli G; Bennati C; Morgillo F; Russo A; Dellepiane C; Vallini I; Sforza V; Inno A; Rastelli F; Tassi V; Nicolardi L; Pensieri V; Emili R; Roca E; Migliore A; Galassi T; Rocchi MLB; Berardi R
    ESMO Open; 2022 Apr; 7(2):100406. PubMed ID: 35219245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study.
    Mentrasti G; Cantini L; Vici P; D'Ostilio N; La Verde N; Chiari R; Paolucci V; Crocetti S; De Filippis C; Pecci F; Di Lisa FS; Traisci D; Cona MS; Nicolardi L; Pizzuti L; Gildetti S; Oldani S; Della Mora A; Bruno Rocchi ML; Berardi R
    Breast; 2022 Oct; 65():164-171. PubMed ID: 35998429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study.
    Mentrasti G; Cantini L; Zichi C; D'Ostilio N; Gelsomino F; Martinelli E; Chiari R; La Verde N; Bisonni R; Cognigni V; Pinterpe G; Pecci F; Migliore A; Aimar G; De Vita F; Traisci D; Spallanzani A; Martini G; Nicolardi L; Cona MS; Baleani MG; Rocchi MLB; Berardi R
    Oncologist; 2022 Sep; 27(9):e723-e730. PubMed ID: 35815922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the COVID-19 pandemic on head and neck cancer diagnosis: data from a single referral center, South Tyrol, northern Italy.
    Gazzini L; Fazio E; Dallari V; Accorona R; Abousiam M; Nebiaj A; Giorgetti G; Girolami I; Vittadello F; Magnato R; Patscheider M; Mazzoleni G; Calabrese L
    Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3159-3166. PubMed ID: 34739577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave.
    Bertaglia V; Reale ML; Bironzo P; Palesandro E; Mariniello A; Leone G; Tabbò F; Bungaro M; Audisio M; Rapetti S; Di Stefano RF; Carnio S; Artusio E; Capelletto E; Sperone P; Passiglia F; Novello S
    Crit Rev Oncol Hematol; 2021 Jan; 157():103189. PubMed ID: 33341505
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.